BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hannoun Z, Steichen C, Dianat N, Weber A, Dubart-Kupperschmitt A. The potential of induced pluripotent stem cell derived hepatocytes. J Hepatol. 2016;65:182-199. [PMID: 26916529 DOI: 10.1016/j.jhep.2016.02.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Yovchev MI, Lee EJ, Rodriguez-Silva W, Locker J, Oertel M. Biliary Obstruction Promotes Multilineage Differentiation of Hepatic Stem Cells. Hepatol Commun 2019;3:1137-50. [PMID: 31388633 DOI: 10.1002/hep4.1367] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gaillard M, Tranchart H, Lainas P, Trassard O, Remy S, Dubart‐kupperschmitt A, Dagher I. Improving Hepatocyte Engraftment Following Hepatocyte Transplantation Using Repeated Reversible Portal Vein Embolization in Rats. Liver Transpl 2019;25:98-110. [DOI: 10.1002/lt.25364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Fath-Bayati L, Vasei M, Sharif-Paghaleh E. Optical fluorescence imaging with shortwave infrared light emitter nanomaterials for in vivo cell tracking in regenerative medicine. J Cell Mol Med 2019;23:7905-18. [PMID: 31559692 DOI: 10.1111/jcmm.14670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pan T, Chen Y, Zhuang Y, Yang F, Xu Y, Tao J, You K, Wang N, Wu Y, Lin X, Wu F, Liu Y, Li Y, Wang G, Li YX. Synergistic modulation of signaling pathways to expand and maintain the bipotency of human hepatoblasts. Stem Cell Res Ther 2019;10:364. [PMID: 31791391 DOI: 10.1186/s13287-019-1463-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hosseini V, Maroufi NF, Saghati S, Asadi N, Darabi M, Ahmad SNS, Hosseinkhani H, Rahbarghazi R. Current progress in hepatic tissue regeneration by tissue engineering. J Transl Med 2019;17:383. [PMID: 31752920 DOI: 10.1186/s12967-019-02137-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
6 Vilaseca M, Guixé-Muntet S, Fernández-Iglesias A, Gracia-Sancho J. Advances in therapeutic options for portal hypertension. Therap Adv Gastroenterol 2018;11:1756284818811294. [PMID: 30505350 DOI: 10.1177/1756284818811294] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
7 Rossi EA, Quintanilha LF, Nonaka CKV, Souza BSF. Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold. Stem Cells Int 2019;2019:2693189. [PMID: 31198426 DOI: 10.1155/2019/2693189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
8 Wang Y, Hay DC. Mass production of stem cell derived human hepatocytes for experimental medicine. Expert Rev Gastroenterol Hepatol 2016;10:769-71. [PMID: 27145120 DOI: 10.1080/17474124.2016.1182862] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Moradi S, Mahdizadeh H, Šarić T, Kim J, Harati J, Shahsavarani H, Greber B, Moore JB 4th. Research and therapy with induced pluripotent stem cells (iPSCs): social, legal, and ethical considerations. Stem Cell Res Ther 2019;10:341. [PMID: 31753034 DOI: 10.1186/s13287-019-1455-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
10 Parafati M, Bae SH, Kirby RJ, Fitzek M, Iyer P, Engkvist O, Smith DM, Malany S. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation. Int J Mol Sci 2020;21:E9557. [PMID: 33334026 DOI: 10.3390/ijms21249557] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Witek RP, Bonzo JA. Perspective on In Vitro Liver Toxicity Models. Applied In Vitro Toxicology 2018;4:229-31. [DOI: 10.1089/aivt.2018.29017.wit] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Kulkarni S, Rudnick DA. Induced Pluripotent Stem Cell-Derived Hepatocytes and Precision Medicine in Human Liver Disease. J Pediatr Gastroenterol Nutr 2018;66:716-9. [PMID: 29509632 DOI: 10.1097/MPG.0000000000001948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Zhang L, Pu K, Liu X, Bae SDW, Nguyen R, Bai S, Li Y, Qiao L. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. Front Med (Lausanne) 2021;8:644594. [PMID: 34277651 DOI: 10.3389/fmed.2021.644594] [Reference Citation Analysis]
14 Polidoro MA, Ferrari E, Marzorati S, Lleo A, Rasponi M. Experimental liver models: From cell culture techniques to microfluidic organs-on-chip. Liver Int 2021;41:1744-61. [PMID: 33966344 DOI: 10.1111/liv.14942] [Reference Citation Analysis]
15 Michalik M, Gładyś A, Czekaj P. Differentiation of Cells Isolated from Afterbirth Tissues into Hepatocyte-Like Cells and Their Potential Clinical Application in Liver Regeneration. Stem Cell Rev Rep 2021;17:581-603. [PMID: 32974851 DOI: 10.1007/s12015-020-10045-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Yang L, Li LC, Lamaoqiezhong, Wang X, Wang WH, Wang YC, Xu CR. The contributions of mesoderm-derived cells in liver development. Semin Cell Dev Biol 2019;92:63-76. [PMID: 30193996 DOI: 10.1016/j.semcdb.2018.09.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kumar D, Talluri TR, Selokar NL, Hyder I, Kues WA. Perspectives of pluripotent stem cells in livestock. World J Stem Cells 2021; 13(1): 1-29 [PMID: 33584977 DOI: 10.4252/wjsc.v13.i1.1] [Reference Citation Analysis]
18 Jin M, Yi X, Liao W, Chen Q, Yang W, Li Y, Li S, Gao Y, Peng Q, Zhou S. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing. Stem Cell Res Ther 2021;12:84. [PMID: 33494782 DOI: 10.1186/s13287-021-02152-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Messina A, Luce E, Hussein M, Dubart-Kupperschmitt A. Pluripotent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration. Cells 2020;9:E420. [PMID: 32059501 DOI: 10.3390/cells9020420] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
20 Rogal J, Zbinden A, Schenke-Layland K, Loskill P. Stem-cell based organ-on-a-chip models for diabetes research. Adv Drug Deliv Rev 2019;140:101-28. [PMID: 30359630 DOI: 10.1016/j.addr.2018.10.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
21 Khan S, Khan RS, Newsome PN. Cell Therapy for Liver Disease: From Promise to Reality. Semin Liver Dis 2020;40:411-26. [PMID: 33764490 DOI: 10.1055/s-0040-1717096] [Reference Citation Analysis]
22 Broeders M, Herrero-Hernandez P, Ernst MPT, van der Ploeg AT, Pijnappel WWMP. Sharpening the Molecular Scissors: Advances in Gene-Editing Technology. iScience 2020;23:100789. [PMID: 31901636 DOI: 10.1016/j.isci.2019.100789] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
23 Nobakht Lahrood F, Saheli M, Farzaneh Z, Taheri P, Dorraj M, Baharvand H, Vosough M, Piryaei A. Generation of Transplantable Three-Dimensional Hepatic-Patch to Improve the Functionality of Hepatic Cells In Vitro and In Vivo. Stem Cells Dev 2020;29:301-13. [PMID: 31856676 DOI: 10.1089/scd.2019.0130] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
24 Aravalli RN. Generating liver using blastocyst complementation: Opportunities and challenges. Xenotransplantation 2021;28:e12668. [PMID: 33372360 DOI: 10.1111/xen.12668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Tyumentseva MA, Tyumentsev AI, Akimkin VG. Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells. PLoS One 2021;16:e0259812. [PMID: 34752487 DOI: 10.1371/journal.pone.0259812] [Reference Citation Analysis]
26 Wang Z, Li W, Jing H, Ding M, Fu G, Yuan T, Huang W, Dai M, Tang D, Zeng M, Chen Y, Zhang H, Zhu X, Peng Y, Li Q, Yu WF, Yan HX, Zhai B. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening. Theranostics 2019;9:6690-705. [PMID: 31588244 DOI: 10.7150/thno.34520] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
27 Holloway EM, Capeling MM, Spence JR. Biologically inspired approaches to enhance human organoid complexity. Development 2019;146:dev166173. [PMID: 30992275 DOI: 10.1242/dev.166173] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
28 Asumda FZ, Hatzistergos KE, Dykxhoorn DM, Jakubski S, Edwards J, Thomas E, Schiff ER. Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules. Differentiation 2018;101:16-24. [PMID: 29626713 DOI: 10.1016/j.diff.2018.03.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
29 Kang K, Kim Y, Jeon H, Lee SB, Kim JS, Park SA, Kim WD, Yang HM, Kim SJ, Jeong J, Choi D. Three-Dimensional Bioprinting of Hepatic Structures with Directly Converted Hepatocyte-Like Cells. Tissue Eng Part A 2018;24:576-83. [PMID: 28726547 DOI: 10.1089/ten.TEA.2017.0161] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
30 Ali M, Payne SL. Biomaterial-based cell delivery strategies to promote liver regeneration. Biomater Res 2021;25:5. [PMID: 33632335 DOI: 10.1186/s40824-021-00206-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Iansante V, Mitry RR, Filippi C, Fitzpatrick E, Dhawan A. Human hepatocyte transplantation for liver disease: current status and future perspectives. Pediatr Res. 2018;83:232-240. [PMID: 29149103 DOI: 10.1038/pr.2017.284] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
32 Novo E, Cannito S, Parola M. In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future? Stem Cell Investig 2016;3:53. [PMID: 27777942 DOI: 10.21037/sci.2016.09.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Reid LM. Stem/progenitor cells and reprogramming (plasticity) mechanisms in liver, biliary tree, and pancreas. Hepatology 2016;64:4-7. [PMID: 27102721 DOI: 10.1002/hep.28606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
34 Gilgenkrantz H, Collin de l'Hortet A. Understanding Liver Regeneration: From Mechanisms to Regenerative Medicine. Am J Pathol. 2018;188:1316-1327. [PMID: 29673755 DOI: 10.1016/j.ajpath.2018.03.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
35 Tasnim F, Huang X, Lee CZW, Ginhoux F, Yu H. Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury. Front Toxicol 2021;3:605392. [PMID: 35295156 DOI: 10.3389/ftox.2021.605392] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kim S, Jeon JM, Kwon OK, Choe MS, Yeo HC, Peng X, Cheng Z, Lee MY, Lee S. Comparative Proteomic Analysis Reveals the Upregulation of Ketogenesis in Cardiomyocytes Differentiated from Induced Pluripotent Stem Cells. Proteomics 2019;19:e1800284. [PMID: 30724459 DOI: 10.1002/pmic.201800284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
37 Tricot T, Verfaillie CM, Kumar M. Current Status and Challenges of Human Induced Pluripotent Stem Cell-Derived Liver Models in Drug Discovery. Cells 2022;11:442. [DOI: 10.3390/cells11030442] [Reference Citation Analysis]
38 Shiota G, Itaba N. Progress in stem cell-based therapy for liver disease. Hepatol Res. 2017;47:127-141. [PMID: 27188253 DOI: 10.1111/hepr.12747] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
39 Abbott A, Coburn JM. HepaRG Maturation in Silk Fibroin Scaffolds: Toward Developing a 3D In Vitro Liver Model. ACS Biomater Sci Eng 2021. [PMID: 34105934 DOI: 10.1021/acsbiomaterials.0c01584] [Reference Citation Analysis]
40 Lee CW, Chen YF, Wu HH, Lee OK. Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases. Gastroenterology. 2018;154:46-56. [PMID: 29107021 DOI: 10.1053/j.gastro.2017.09.049] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
41 Scarfe L, Brillant N, Kumar JD, Ali N, Alrumayh A, Amali M, Barbellion S, Jones V, Niemeijer M, Potdevin S, Roussignol G, Vaganov A, Barbaric I, Barrow M, Burton NC, Connell J, Dazzi F, Edsbagge J, French NS, Holder J, Hutchinson C, Jones DR, Kalber T, Lovatt C, Lythgoe MF, Patel S, Patrick PS, Piner J, Reinhardt J, Ricci E, Sidaway J, Stacey GN, Starkey Lewis PJ, Sullivan G, Taylor A, Wilm B, Poptani H, Murray P, Goldring CEP, Park BK. Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies. NPJ Regen Med 2017;2:28. [PMID: 29302362 DOI: 10.1038/s41536-017-0029-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
42 Zakikhan K, Pournasr B, Vosough M, Nassiri-Asl M. In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery. Cell J 2017;19:204-17. [PMID: 28670513 DOI: 10.22074/cellj.2016.4362] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
43 Carpino G, Gaudio E. Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives. Stem Cell Investig 2016;3:91. [PMID: 28078271 DOI: 10.21037/sci.2016.11.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Guo X, Li W, Ma M, Lu X, Zhang H. Endothelial cell-derived matrix promotes the metabolic functional maturation of hepatocyte via integrin-Src signalling. J Cell Mol Med 2017;21:2809-22. [PMID: 28470937 DOI: 10.1111/jcmm.13195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 Duncan SA. Liver Capsule: Multipotent stem cells and their lineage restriction to hepatocytes. Hepatology 2016;64:1330. [PMID: 27405444 DOI: 10.1002/hep.28727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Choi J, Kang S, Kim B, So S, Han J, Kim GN, Lee MY, Roh S, Lee JY, Oh SJ, Sung YH, Lee Y, Kim SH, Kang E. Efficient hepatic differentiation and regeneration potential under xeno-free conditions using mass-producible amnion-derived mesenchymal stem cells. Stem Cell Res Ther 2021;12:569. [PMID: 34772451 DOI: 10.1186/s13287-021-02470-y] [Reference Citation Analysis]
47 Fermini B, Coyne ST, Coyne KP. Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development. SLAS Discov 2018;23:765-76. [PMID: 29862873 DOI: 10.1177/2472555218775028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
48 Kumar D, Anand T, Talluri TR, Kues WA. Potential of transposon-mediated cellular reprogramming towards cell-based therapies. World J Stem Cells 2020; 12(7): 527-544 [PMID: 32843912 DOI: 10.4252/wjsc.v12.i7.527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ghosh S, Börsch A, Ghosh S, Zavolan M. The transcriptional landscape of a hepatoma cell line grown on scaffolds of extracellular matrix proteins. BMC Genomics 2021;22:238. [PMID: 33823809 DOI: 10.1186/s12864-021-07532-2] [Reference Citation Analysis]
50 Fairhall EA, Leitch AC, Lakey AF, Abdelghany TM, Ibrahim I, Tosh D, Kass GEN, Wilson C, Wright MC. HNF4alpha expression amplifies the glucocorticoid-induced conversion of a human pancreatic cell line to an hepatocyte-like cell. Biochem Biophys Res Commun 2018;503:1633-40. [PMID: 30057318 DOI: 10.1016/j.bbrc.2018.07.092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Pasqua M, Di Gesù R, Chinnici CM, Conaldi PG, Francipane MG. Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening. Int J Mol Sci 2021;22:8227. [PMID: 34360991 DOI: 10.3390/ijms22158227] [Reference Citation Analysis]
52 Garnier D, Li R, Delbos F, Fourrier A, Collet C, Guguen-Guillouzo C, Chesné C, Nguyen TH. Expansion of human primary hepatocytes in vitro through their amplification as liver progenitors in a 3D organoid system. Sci Rep 2018;8:8222. [PMID: 29844473 DOI: 10.1038/s41598-018-26584-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
53 Yuan L, Zhang Y, Liu X, Chen Y, Zhang L, Cao J, Li X, Wang M, Wu K, Zhang J, Liu G, Tang Q, Yuan Q, Cheng T, Xia N. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice. Theranostics 2019;9:2115-28. [PMID: 31037160 DOI: 10.7150/thno.30009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
54 Lee YS, Park KM, Yu L, Kwak HH, Na HJ, Kang KS, Woo HM. Necroptosis Is a Mechanism of Death in Mouse Induced Hepatocyte-Like Cells Reprogrammed from Mouse Embryonic Fibroblasts. Mol Cells 2018;41:639-45. [PMID: 29991669 DOI: 10.14348/molcells.2018.2353] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Agarwal N, Popovic B, Martucci NJ, Fraunhoffer NA, Soto-Gutierrez A. Biofabrication of Autologous Human Hepatocytes for Transplantation: How Do We Get There? Gene Expr 2019;19:89-95. [PMID: 30143060 DOI: 10.3727/105221618X15350366478989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Li PP, Gu C, Liang BY, Wang L, Zhou Y, Tan WS. A serum-free medium suitable for maintaining cell morphology and liver-specific function in induced human hepatocytes. Cytotechnology 2019;71:329-44. [PMID: 30603919 DOI: 10.1007/s10616-018-0289-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Giancotti A, Monti M, Nevi L, Safarikia S, D’Ambrosio V, Brunelli R, Pajno C, Corno S, Di Donato V, Musella A, Chiappetta MF, Bosco D, Panici PB, Alvaro D, Cardinale V. Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine. Cells 2019;8:E914. [PMID: 31426422 DOI: 10.3390/cells8080914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
58 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
59 Yoon S, Kang K, Cho YD, Kim Y, Buisson EM, Yim JH, Lee SB, Ryu KY, Jeong J, Choi D. Nonintegrating Direct Conversion Using mRNA into Hepatocyte-Like Cells. Biomed Res Int 2018;2018:8240567. [PMID: 30327781 DOI: 10.1155/2018/8240567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Cotovio JP, Fernandes TG. Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications. Bioengineering (Basel) 2020;7:E36. [PMID: 32283585 DOI: 10.3390/bioengineering7020036] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
61 Tolosa L, Pareja E, Gómez-Lechón MJ. Clinical Application of Pluripotent Stem Cells: An Alternative Cell-Based Therapy for Treating Liver Diseases? Transplantation 2016;100:2548-57. [PMID: 27495745 DOI: 10.1097/TP.0000000000001426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]